IceCure Medical Ltd. (ICCM)
About IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $3.4M
- Net income
- -$15.1M
- Total assets
- $13.9M
- Market cap
- $12.3M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $12.3M
- Shares outstanding
- 4.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 6, 2013
IceCure Medical Ltd. (ICCM) Stock Price
- Reported a net loss of $15.1M in FY2025.
- Trading 91% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review IceCure Medical Ltd..
Write a review
News about IceCure Medical Ltd.
News & sentiment via Polygon.io
IceCure Medical Ltd.: frequently asked questions
Is IceCure Medical Ltd. an American company?
IceCure Medical Ltd. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is IceCure Medical Ltd. publicly traded?
Yes — IceCure Medical Ltd. is a publicly traded company. Its stock trades under the ticker symbol ICCM on the NASDAQ.
What does IceCure Medical Ltd. do?
IceCure Medical Ltd. is an American Medical Devices company in the Health & Beauty sector.
